Literature DB >> 24039765

Phylodynamics of the HIV-1 epidemic in Cuba.

Edson Delatorre1, Gonzalo Bello.   

Abstract

Previous studies have shown that the HIV-1 epidemic in Cuba displayed a complex molecular epidemiologic profile with circulation of several subtypes and circulating recombinant forms (CRF); but the evolutionary and population history of those viral variants remains unknown. HIV-1 pol sequences of the most prevalent Cuban lineages (subtypes B, C and G, CRF18_cpx, CRF19_cpx, and CRFs20/23/24_BG) isolated between 1999 and 2011 were analyzed. Maximum-likelihood analyses revealed multiple introductions of subtype B (n≥66), subtype C (n≥10), subtype G (n≥8) and CRF18_cpx (n≥2) viruses in Cuba. The bulk of HIV-1 infections in this country, however, was caused by dissemination of a few founder strains probably introduced from North America/Europe (clades B(CU-I) and B(CU-II)), east Africa (clade C(CU-I)) and central Africa (clades G(CU), CRF18(CU) and CRF19(CU)), or locally generated (clades CRFs20/23/24_BG). Bayesian-coalescent analyses show that the major HIV-1 founder strains were introduced into Cuba during 1985-1995; whereas the CRFs_BG strains emerged in the second half of the 1990s. Most HIV-1 Cuban clades appear to have experienced an initial period of fast exponential spread during the 1990s and early 2000s, followed by a more recent decline in growth rate. The median initial growth rate of HIV-1 Cuban clades ranged from 0.4 year⁻¹ to 1.6 year⁻¹. Thus, the HIV-1 epidemic in Cuba has been a result of the successful introduction of a few viral strains that began to circulate at a rather late time of the AIDS pandemic, but then were rapidly disseminated through local transmission networks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24039765      PMCID: PMC3767668          DOI: 10.1371/journal.pone.0072448

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The global dissemination of the Human immunodeficiency virus type 1 (HIV-1) group M clade during the second half of the twentieth century has resulted in the generation of a diverse collection of genetic variants classified into subtypes, sub-subtypes, circulating recombinant forms (CRFs) and unique recombinants forms (URFs). The HIV-1 epidemic in the Americas is typically dominated by subtype B clade, although substantial proportions (≥20%) of non-B subtype genetic forms are observed in Argentina, Brazil, Cuba and Uruguay [1]. Cuba displayed a unique HIV-1 molecular epidemiologic profile in the Americas characterized by the co-circulation of several subtypes (A1, B, C, F1, G, H and J), CRFs and URFs. Subtype B is the most prevalent variant (∼33–40%), followed by CRF19_cpx (∼20–28%), CRFs20/23/24_BG (∼12–20%) CRF18_cpx (∼7–10%), subtype C (∼3–10%), and subtype G (∼2–7%) [2], [3], [4], [5], [6], [7]. It has been proposed that the presence of numerous Cuban military and civilian personnel in several sub-Saharan African countries, and particularly those stationed in Angola and neighboring countries between 1975 and 1991, have contributed to the introduction of multiple non-B HIV-1 subtypes into Cuba [2]. Some HIV-1 recombinants including CRF18_cpx and CRF19_cpx were probably also imported into Cuba directly from central Africa, since the parental viruses of these complex genetic forms were only detected in that African region [8], [9]. Indeed, a few cases of CRF18_cpx and CRF19_cpx like viruses have been confirmed in Angola [10], [11], Democratic Republic of Congo (DRC) [12], [13], Republic of Congo [14], [15], Central African Republic [16], and Cameroon [17], [18], [19]. Other HIV-1 recombinants including all three CRFs_BG, however, were probably generated locally by recombination between subtypes B and G already circulating in Cuba [20]. According to this model, most non-B subtype HIV-1 variants circulating in Cuba were probably introduced or locally generated after 1975. Despite the extensive knowledge about the molecular epidemiology of HIV-1 variants, the time-scale and epidemic history of most prevalent HIV-1 clades circulating in Cuba remains to be elucidated. In this study, we used a Bayesian coalescent-based method and a comprehensive data set of HIV-1 subtype B (n = 322), and non-B subtypes (n = 420) pol sequences of Cuban origin isolated between 1999 and 2011, to date the origin and reconstruct the demographic history of major HIV-1 variants circulating in Cuba.

Materials and Methods

HIV-1 Cuban sequence datasets

We downloaded all HIV-1 Cuban sequences covering the entire protease and partial reverse transcriptase (PR/RT) regions of the pol gene (nt 2253–3272 relative to HXB2 clone) classified as subtypes B (n = 322), C (n = 49), G (n = 35), CRF18_cpx (n = 71), CRF19_cpx (n = 167), and CRFs20/23/24_BG (n = 118) that were available at the Los Alamos HIV Sequence Database (www.hiv.lanl.gov) by March 2013. HIV-1 pol sequences were retrieved from both antiretroviral therapy naïve and HAART treated patients from different Cuban regions between 1999 and 2011, as described in previous studies [2], [3], [4], [5], [6]. Sequences were aligned using the CLUSTAL X program [21]. To avoid any bias on the phylogenetic reconstructions, all sites with major antiretroviral drug resistance mutations in PR (30, 32, 46, 47, 48, 50, 54, 76, 82, 84, 88 and 90) or RT (41, 65, 67, 69, 70, 74, 100, 101, 103, 106, 115, 138, 151, 181, 184, 188, 190, 210, 215, 219 and 230) detected in at least two sequences were excluded from each alignment. All alignments are available from the authors upon request.

HIV-1 reference datasets

HIV-1 Cuban sequences were combined with reference sequences of diverse origin that matched the selected genomic region and were available at the Los Alamos HIV Sequence Database. Subtype B Cuban sequences were aligned with reference sequences representative of the viral diversity in US (n = 525), France (n = 348) and the Caribbean (n = 417) (Table S1). Subtype C Cuban sequences were aligned with representative sequences from central (n = 53), eastern (n = 330) and southern (n = 545) African regions (Table S2). The HIV-1 subtype G Cuban sequences were combined with all available subtype G sequences of African origin (n = 437) (Table S3). The CRF19_cpx Cuban sequences were aligned with all available CRF19_cpx sequences from other countries (n = 3) and subtype D sequences of African origin (n = 1,112) (Table S4). Finally, the HIV-1 CRF18_cpx and CRFs_BG Cuban sequences were combined with all available CRF18_cpx (n = 15) and CRFs20/23/24_BG (n = 7) sequences from other countries (Tables S4 and S5).

Subtype assignment

The subtype assignment and recombinant structure of all sequences here included was confirmed by: REGA HIV subtyping tool v.2 [22]; Bootscanning with Simplot software v3.5.1 [23] and Maximum Likelihood (ML) phylogenetic analysis. In bootscan analyses, supporting branching with reference sequences from all HIV-1 group M subtypes were determined in Neighbor-Joining trees based on 100 re-samplings, within a 250 bp window moving in steps of 10 bases. ML phylogenetic trees were inferred under the best nucleotide substitution model selected using the jModeltest program [24] (Table S6). The ML tree was reconstructed with the PhyML program [25] using an online web server [26]. Heuristic tree search was performed using the SPR branch-swapping algorithm and the reliability of the obtained topology was estimated with the approximate likelihood-ratio test (aLRT) [27] based on the Shimodaira-Hasegawa-like procedure. The ML trees were visualized using the FigTree v1.4.0 program [28]. All HIV-1 sequences displaying incorrect clade assignment and/or frameshift mutations were excluded from the study, with the exception of four CRF23_BG sequences that were reclassified as CRF20_BG (GenBank accession numbers FJ481689 and FJ585687) and CRF24_BG (GenBank accession numbers JQ585465 and FJ481688).

Reconstruction of evolutionary and demographic history

The evolutionary rate (μ, nucleotide substitutions per site per year, subst./site/year), the age of the most recent common ancestor (T mrca, years), and the mode and rate (r, years−1) of population growth of different Cuban HIV-1 clades were jointly estimated using the Bayesian Markov Chain Monte Carlo (MCMC) approach as implemented in BEAST v1.7.5 [29], [30]. Analyses were performed using the best nucleotide substitution model (Table S6) and an uncorrelated Lognormal relaxed molecular clock model [31]. A Bayesian Skyline coalescent tree prior [32] was first used to estimate μ, the T mrca, and the change in effective population size through time. Estimates of the population growth rate were subsequently obtained using a logistic growth coalescent tree prior that was the model pointed out by the Bayesian Skyline plot and that also provided the best fit to the demographic signal contained in most datasets. Comparison between demographic models was performed using the log marginal likelihood (ML) estimation based on path sampling (PS) and stepping-stone sampling (SS) methods [33]. MCMC chains were run for 10–50×106 generations. Adequate chain mixing and uncertainty in parameter estimates were assessed by calculating the effective sample size (ESS) and the 95% Highest Probability Density (HPD) values respectively, after excluding an initial 10% using the TRACER v1.5 program [34].

Results

Identification of major HIV-1 Cuban clades

The ML analysis of HIV-1 subtypes B, C and G sequences from Cuba and other countries from the Americas, Europe and Africa revealed that most Cuban strains branched in well-supported country-specific sub-clades. Of the 322 HIV-1 subtype B Cuban sequences analyzed, 180 (56%) formed a large country-specific monophyletic sub-clade (BCU-I, aLRT = 0.81), 44 (14%) branched in two clusters of medium size (15
Figure 1

ML phylogenetic tree of HIV-1 subtype B pol (∼1000 pb) sequences circulating in Cuba (n = 322), US (n = 525), France (n = 348), and other Caribbean countries (n = 418).

The branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). The circular brackets highlight the position of the pandemic (BPANDEMIC, green line) and non-pandemic (BCARIBBEAN, blue line) HIV-1 subtype B clades. Shaded boxes highlight the position of the two major HIV-1 subtype B Cuban clades (BCU-I and BCU-II). The number of Cuban sequences distributed accordingly to the clade size is shown (top left). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The tree was rooted using HIV-1 subtype D reference sequences (gray branches). The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.

ML phylogenetic tree of HIV-1 subtype B pol (∼1000 pb) sequences circulating in Cuba (n = 322), US (n = 525), France (n = 348), and other Caribbean countries (n = 418).

The branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). The circular brackets highlight the position of the pandemic (BPANDEMIC, green line) and non-pandemic (BCARIBBEAN, blue line) HIV-1 subtype B clades. Shaded boxes highlight the position of the two major HIV-1 subtype B Cuban clades (BCU-I and BCU-II). The number of Cuban sequences distributed accordingly to the clade size is shown (top left). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The tree was rooted using HIV-1 subtype D reference sequences (gray branches). The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site. Of the 49 HIV-1 subtype C Cuban sequences analyzed, 34 (69%) branched in a single monophyletic sub-cluster (CCU-I, aLRT = 0.94), six (12%) branched in a second well supported minor clade (CCU-II, aLRT = 0.98), and the remaining nine (18%) represented non-clustered sporadic lineages (Fig. 2). The major clade CCU-I was nested within Ethiopian sequences that belongs to the previously called CEA clade [35], a viral lineage characteristic of the east African region (Fig. 2). The minor clade CCU-II, by contrast, was nested within subtype C sequences from southern Africa (Fig. 2). Non-clustered Cuban sequences were scattered among strains from Ethiopia and southern African countries.
Figure 2

ML phylogenetic tree of HIV-1 subtype C pol (∼1000 pb) sequences circulating in Cuba (n = 49), and in central (n = 53), eastern (n = 330) and southern (n = 545) African countries.

Branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). The circular bracket highlights the position of the subtype C east African clade (CEA). Shaded boxes highlight the position of the two major HIV-1 subtype C Cuban clades (CCU-I and CCU-II). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The tree was rooted using HIV-1 subtype A1 and D reference sequences (gray branches). The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.

ML phylogenetic tree of HIV-1 subtype C pol (∼1000 pb) sequences circulating in Cuba (n = 49), and in central (n = 53), eastern (n = 330) and southern (n = 545) African countries.

Branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). The circular bracket highlights the position of the subtype C east African clade (CEA). Shaded boxes highlight the position of the two major HIV-1 subtype C Cuban clades (CCU-I and CCU-II). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The tree was rooted using HIV-1 subtype A1 and D reference sequences (gray branches). The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site. Of the 35 HIV-1 subtype G Cuba sequences analyzed, 26 (74%) branched in a single monophyletic sub-cluster (GCU, aLRT = 0.87) and the remaining nine (26%) represented sporadic lineages of one or two sequences. Although most subtype G African strains included in our analysis were from the western region (n = 366, 84%), the clade GCU and most sporadic subtype G Cuban lineages were nested among basal sequences from the central African region (Angola, DRC and Cameroon) (Fig. 3). There was only one Cuban sequence that branched within a major African subtype G sub-clade mainly composed by sequences from Nigeria.
Figure 3

ML phylogenetic tree of HIV-1 subtype G pol (∼1000 pb) sequences circulating in Cuba (n = 35), and in central (n = 71), western (n = 366), eastern (n = 10) and southern (n = 3) African countries.

Branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). Shaded boxes highlight the position of the major HIV-1 subtype G Cuban clade (GCU). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The tree was rooted using HIV-1 subtype A1 and B reference sequences (gray branches). The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.

ML phylogenetic tree of HIV-1 subtype G pol (∼1000 pb) sequences circulating in Cuba (n = 35), and in central (n = 71), western (n = 366), eastern (n = 10) and southern (n = 3) African countries.

Branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). Shaded boxes highlight the position of the major HIV-1 subtype G Cuban clade (GCU). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The tree was rooted using HIV-1 subtype A1 and B reference sequences (gray branches). The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site. Test the monophyletic origin of the HIV-1 CRFs_cpx Cuban sequences was very much complicated because the scarcity of CRF18_cpx (n = 12) and the absence of CRF19_cpx pol sequences of African origin available in public databases. Because CRF19_cpx is subtype D in the pol fragment analyzed, we decided to include all available subtype D pol sequences of African origin in our analysis. ML analysis revealed that all (except one) CRF18_cpx and all CRF19_cpx sequences from Cuba branched in highly supported (aLRT≥0.90) monophyletic sub-clusters (CRF18CU and CRF19CU) that were nested within CRF18_cpx and subtype D pol sequences of central African origin, respectively (Fig. 4). The few CRF18_cpx isolated in Europe (n = 2) and South America (n = 1) were intermixed among basal African strains; whereas all CRF19_cpx detected in Europe (n = 3) branched within the clade CRF19CU (Fig. 4).
Figure 4

ML phylogenetic trees of HIV-1 CRFs_cpx pol (∼1000 pb) sequences.

A) HIV-1 CRF18_cpx from Cuba (n = 62), were combined with those isolated in African (n = 12), American (n = 1) and European (n = 2) countries. The tree was rooted using HIV-1 subtype G reference sequences (black branches). B) HIV-1 CRF19_cpx sequences from Cuba (n = 160) and European countries (n = 3) were combined with subtype D sequences of African origin (n = 1,112). Branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). Shaded boxes highlight the position of the major HIV-1 CRF18_cpx (CRF18CU) and CRF19_cpx (CRF19CU) Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.

ML phylogenetic trees of HIV-1 CRFs_cpx pol (∼1000 pb) sequences.

A) HIV-1 CRF18_cpx from Cuba (n = 62), were combined with those isolated in African (n = 12), American (n = 1) and European (n = 2) countries. The tree was rooted using HIV-1 subtype G reference sequences (black branches). B) HIV-1 CRF19_cpx sequences from Cuba (n = 160) and European countries (n = 3) were combined with subtype D sequences of African origin (n = 1,112). Branches are colored according to the origin of each sequence, as indicated at the legend (bottom left). Shaded boxes highlight the position of the major HIV-1 CRF18_cpx (CRF18CU) and CRF19_cpx (CRF19CU) Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site. As expected, the CRFs20/23/24_BG Cuban sequences formed three well-supported (aLRT≥0.90) monophyletic lineages (Fig. 5). The few CRF20_BG (n = 4) and CRF24_BG (n = 3) sequences isolated outside Cuba (Spain and Greece) were intermixed among Cuban strains (Fig. 5); thus supporting a Cuban origin for all those European sequences.
Figure 5

Ml phylogenetic tree of HIV-1 CRFs20/23/24_BG pol (∼1000 pb) sequences circulating in Cuba (n = 118) and Spain (n = 7).

Branches are colored according to the origin of each sequence, as indicated at the legend (top left). The circular brackets highlight the distribution of the three CRFs_BG clades. The tree was rooted using HIV-1 subtype G reference sequences (black branches). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.

Ml phylogenetic tree of HIV-1 CRFs20/23/24_BG pol (∼1000 pb) sequences circulating in Cuba (n = 118) and Spain (n = 7).

Branches are colored according to the origin of each sequence, as indicated at the legend (top left). The circular brackets highlight the distribution of the three CRFs_BG clades. The tree was rooted using HIV-1 subtype G reference sequences (black branches). Key nodes with aLRT support values >0.80 (*) and ≥0.90 (**) are indicated. The branch lengths are drawn to scale with the bar at the bottom indicating nucleotide substitutions per site.

Time scale of major HIV-1 Cuban clades

Bayesian MCMC analyses under a relaxed molecular clock model were used to estimate the substitution rate and TMRCA of all HIV-1 Cuban clades with a minimum size of 25 sequences. A few subtype B (n = 4) and CRF19_cpx (n = 2) sequences with anomalously long branches in the phylogenetic tree, were excluded. The final number of HIV-1 Cuban sequences included in the evolutionary analyses is shown in Table 1. The median estimated evolutionary rates for the pol region of the different HIV-1 clades were roughly similar, ranging from 2.0×10−3 subst./site/year (GCU clade) to 3.4×10−3 subst./site/year (CRF19CU clade), with a considerable overlap of the 95% HPD intervals (Table 1). The coefficient of rate variation was higher than zero for all HIV-1 datasets analyzed (Table 1), thus supporting the use of a relaxed molecular clock model to reconstruct the time-scale of major HIV-1 Cuban lineages.
Table 1

Evolutionary rate and time-scale of major HIV-1 Cuban clades.

HIV-1 clade N Sampling interval μ (subst./site/year)Coefficient of variationTMRCA
BCU-I 1762003–20113.0×10−3 0.301992
(2.4×10−3–3.6×10−3)(0.21–0.39)(1988–1994)
BCU-II 271999–20112.4×10−3 0.251991
(1.6×10−3–3.2×10−3)(0.01–0.45)(1986–1994)
CCU 342003–20112.8×10−3 0.411994
(2.0×10−3–3.8×10−3)(0.19–0.65)(1990–1998)
GCU 261999–20112.0×10−3 0.561988
(1.0×10−3–3.3×10−3)(0.36–0.81)(1976–1995)
CRF18CU 611999–20112.6×10−3 0.401992
(1.9×10−3–3.5×10−3)(0.25–0.59)(1987–1996)
CRF19CU 1581999–20113.4×10−3 0.381987
(2.9×10−3–4.0×10−3)(0.30–0.47)(1983–1991)
CRF20/23/24_BG1171999–20112.6×10−3 0.351991
(2.1×10−3–3.1×10−3)* (0.25–0.45)* (1986–1994)*
CRF20_BG561999–20112.6×10−3 0.351996
(2.1×10−3–3.1×10−3)* (0.25–0.45)* (1994–1998)*
2.4×10−3 0.271996
(1.8×10−3–3.0×10−3)(0.10–0.44)(1994–1998)
CRF23_BG112003–20112.6×10−3 0.351998
(2.1×10−3–3.1×10−3)* (0.25–0.45)* (1996–2000)*
CRF24_BG502003–20112.6×10−3 0.351997
(2.1×10−3–3.1×10−3)* (0.25–0.45)* (1996–1999)*
2.2×10−3 0.361998
(1.6×10−3–2.8×10−3)(0.19–0.54)(1996–2000)

Estimates obtained from the combined CRF20/23/24_BG data set.

Estimates obtained from the combined CRF20/23/24_BG data set. The median TMRCA of those HIV-1 clades imported into Cuba range between 1987 (CRF19CU) and 1994 (CCU-I); whereas the median TMRCA of those CRF_BG variants locally generated varied between 1996 and 1998 (Table 1). The TMRCA of CRF20_BG and CRF24_BG clades estimated from the single CRF datasets were almost identical to those estimated from the combined CRFs20/23/24_BG data set (Table 1), indicating that all Cuban CRFs_BG evolved at quite similar rates. A previous study [20], proposed that Cuban CRF_BG viruses derive from a common recombinant ancestor generated by recombination between clade GCU and the second most prevalent subtype B clade (BCU-II) (Fig. 1). The analysis of the combined CRFs20/23/24_BG data set allows us to estimate the median TMRCA of that putative BG recombinant ancestor at 1991, roughly coinciding with the estimated TMRCA of the parental clades GCU and BCU-II (Table 1).

Demographic history of major HIV-1 Cuban clades

The Bayesian skyline plot (BSP) analyses suggest that all HIV-1 Cuban clades experienced an initial phase of fast exponential growth followed by a more recent decline in growth rate (Fig. 6). The growth rate of most HIV-1 Cuban clades seems to start to decrease around the early 2000s; except for clades BCU-II and CRF24_BG that seem to stabilize at earlier (before 2000) and later (after 2005) time points, respectively. The BSP analyses also suggests that the coalescent model of logistic population growth fits the demographic information contained in all HIV-1 Cuban data sets better than the exponential one.
Figure 6

Demographic history of the major HIV-1 Cuban clades.

Effective number of infections through time estimated using both Bayesian skyline (A, C, E, G, I, K, M and O) and logistic growth (B, D, F, H, J, L, N and P) coalescent models are shown for each of the eight HIV-1 Cuban clades analyzed. Median estimates of the effective number of infections (solid line) and 95% HPD intervals of the estimates (dashed lines) are shown in each graphic. The vertical axes represent the estimated effective number of infections on a logarithmic scale. Time scale is in calendar years.

Demographic history of the major HIV-1 Cuban clades.

Effective number of infections through time estimated using both Bayesian skyline (A, C, E, G, I, K, M and O) and logistic growth (B, D, F, H, J, L, N and P) coalescent models are shown for each of the eight HIV-1 Cuban clades analyzed. Median estimates of the effective number of infections (solid line) and 95% HPD intervals of the estimates (dashed lines) are shown in each graphic. The vertical axes represent the estimated effective number of infections on a logarithmic scale. Time scale is in calendar years. To test this, log ML for the logistic and exponential growth models were calculated using both PS and SS methods. The model of logistic population growth was strongly supported over the exponential one for most HIV-1 Cuban clades (log BF>3), with exception of GCU and CRF24_BG for which only a weak support was obtained (log BF = 0.9–1.0) (Table 2). Such a low BF support to the logistic growth model could be explained by the low number of sequences in clade GCU (n = 26) and the very recent stabilization of clade CRF24_BG (after 2005). Moreover, the overall time-scale and demographic pattern obtained from both BSP and logistic growth coalescent tree priors were very similar for all HIV-1 Cuban clades (Fig. 6). According to the logistic model, the median initial growth rates of HIV-1 Cuban clades range between 0.40 year−1 (CRF19CU) to 1.57 year−1 (BCU-II) with some overlap of the 95% HPD intervals for most lineages, except between CRF19CU and clades BCU-I, BCU-II, CCU-I, CRF20_BG and CRF24_BG (Fig. 7).
Table 2

Best fit demographic model for major HIV-1 Cuban clades.

DatasetPSSS
Log ML LGLog ML EGLog BF (LG vs EG)Log ML LGLog ML EGLog BF (LG vs EG)
BCUBA I −12891.71−12935.3943.68−12894.56−12939.4743.91
BCUBA II −3563.92−3568.514.59−3563.99−3568.714.72
CCUBA −4114.63−4118.503.87−4114.74−4118.723.98
GCUBA −4196.64−4197.661.02−4196.87−4197.730.86
CRF18−6109.29−6118.919.62−6109.546119.019.47
CRF19−14552.57−14564.2111.64−14553.91−14565.0911.18
CRF20−5083.74−5100.8017.06−5083.91−5101.0517.14
CRF24−4159.40−4160.431.03−4159.81−4160.700.89

Log marginal likelihood (ML) estimates for logistic growth (LG) and exponential growth (EG) demographic models obtained using the path sampling (PS) and stepping stone sampling (SS) methods. The Log Bayes factor (BF) is the difference of the Log ML between of alternative (H1 = LG) and null (H0 = EG) models. Log BFs>1 indicates that model H1 is more strongly supported by the data than model H0.

Figure 7

Coalescent estimates of epidemic growth rate of the major HIV-1 Cuban clades.

The box plots and the numbers above represent the median growth rates (years−1) and the 95% HPD intervals of the posterior distributions estimated under the logistic growth coalescent model for each of the eight HIV-1 Cuban clades analyzed.

Coalescent estimates of epidemic growth rate of the major HIV-1 Cuban clades.

The box plots and the numbers above represent the median growth rates (years−1) and the 95% HPD intervals of the posterior distributions estimated under the logistic growth coalescent model for each of the eight HIV-1 Cuban clades analyzed. Log marginal likelihood (ML) estimates for logistic growth (LG) and exponential growth (EG) demographic models obtained using the path sampling (PS) and stepping stone sampling (SS) methods. The Log Bayes factor (BF) is the difference of the Log ML between of alternative (H1 = LG) and null (H0 = EG) models. Log BFs>1 indicates that model H1 is more strongly supported by the data than model H0.

Discussion

The Cuban HIV epidemic is unique in the Americas because of the exceptionally low HIV prevalence, estimated at 0.20% in adults in 2011 [36], and the unusually high HIV-1 genetic diversity with circulation of subtype B and several non-B subtypes [2], [3], [4], [5], [6], [7]. Our study indicates that most HIV-1 infections in Cuba derived from the dissemination of a few founder viruses that were either introduced from the Americas/Europe (subtype B) and Africa (subtype C, subtype G, CRF18_cpx and CRF19_cpx) or were locally generated (CRFs20/23/24_BG). The most accepted model of worldwide HIV-1 subtype B dissemination suggests that the virus moved from Haiti to other Caribbean islands and to the United States (US), and then from the US to the rest of the world establishing a “BPANDEMIC” clade [37]. The phylogenetic analysis here performed revealed multiple (n≥66) introductions of HIV-1 BPANDEMIC strains in Cuba, although the bulk of the subtype B epidemic in this country resulted from the dissemination of only a few clades. The two most prevalent clades BCU-I and BCU-II comprises about 55% and 8% of all subtype B sequences from Cuba here included, respectively. We estimate that these clades most probably emerged in Cuba in the early 1990s, much later than the estimated origin of subtype B epidemics in Haiti and the US (1960–1970) [37], [38], [39]. The estimated TMRCA of clades BCU-I and BCU-II coincides with a crisis in the Cuban economy caused by the collapse of the Soviet Union in 1991 that precipitated important investments in the tourist industry and a sharp increase in the number of tourist mostly from North America and Europe [40], regions with a widespread circulation of the subtype BPANDEMIC clade. This may explain the massive influx of subtype BPANDEMIC strains and the apparent absence of “non-pandemic” subtype B Caribbean lineages in Cuba. Similarly to subtype B, there were multiple introductions of subtype C (n≥10), subtype G (n≥8) and CRF18_cpx (n≥2) viruses in Cuba, but only a few of them were able to get established and disseminate. The clades CCU-I, GCU and CRF18CU comprise 69%, 74% and 98% of all subtype C, subtype G and CRF18_cpx sequences from Cuba included in this study, respectively. The monophyletic clustering of CRF19_cpx-like pol Cuban sequences within subtype D radiation, the paucity of this genetic variant in Africa, and the recent TMRCA of Cuban sequences strongly suggests that the CRF19CU clade also derives from a single founder event. HIV-1 clades GCU, CRF18CU and CRF19CU probably originate in central Africa, whereas clade CCU-I probably derives from east Africa. Our study suggests that clades CRF19CU and GCU began to circulate in Cuba around the late 1980s, followed shortly thereafter by clades CRF18CU and CCU-I. Thus, although Cuban personnel were stationed in several African countries since the 1970s, HIV-1 African strains were successfully disseminated within Cuba only from the late 1980s onwards. Our data suggest that HIV-1 CRFs_BG (20_BG, 23_BG and 24_BG) started to spread in Cuba in the second half of the 1990s. Such a recent expansion of BG recombinants in Cuba is fully consistent with epidemiological data showing that in samples collected in 2003, none of the individuals harboring BG recombinants were diagnosed with HIV-1 infection earlier than 1996, and all but three were diagnosed since 2000 [20]. Similarly, the proportion of BG infections among MSM in Havana City increased from 0% in those diagnosed in 1998 to 31% in those diagnosed in 2003 [3]. It was proposed that all Cuban CRFs_BG evolved from a common BG recombinant ancestor locally generated by recombination between parental clades BCU-II and GCU [20]. According to our estimations, that common BG recombinant ancestor was generated in the early 1990s, thus around or immediately after the estimated onset date of parental clades BCU-II and GCU and some years earlier than the emergence of the CRFs_BG. The reconstruction of the demographic history indicates that most HIV-1 Cuban clades followed a very similar growth pattern characterized by rapid dissemination until the early 2000s after which the epidemic growth rate of those epidemics started to slow-down. The expansion of the BCU-II clade, by contrast, seems to decrease during 1990s; whereas the growth rate of the CRF24_BG clade probably only stabilized in the second half of the 2000s. The initial expansion of the major HIV-1 Cuban clades coincides with a sustained increase in the number of infected HIV-positive individuals in Cuba from 1991 to 2000 [41]. UNAIDS estimations indicate that the total number of people living with HIV in Cuba continued to growth in the last decade, rising from 3,100 (2,600–4,300) in 2000 to 14,000 (12,000–16,000) in 2011 [36]. Our demographic analysis, however, suggests a trend toward stability in the effective number of infections of all major HIV-1 Cuban clades over time consistent with recent epidemiological data that shows a decrease of HIV incidence in Cuba, mainly among men, in the biennium 2010–2011 [42]. Our coalescent-based analyses suggest that CRF20_BG, CRF24_BG and BCU-II have displayed a more explosive initial growth (1.0 year−1–1.6 year-1) than clades GCU, CRF18CU and CRF19CU (∼0.4–0.6 year−1); whereas clades BCU-I and CCU-I displayed intermediate initial growth rates (∼0.8 year−1). Notably, all those HIV-1 Cuban clades with the fastest initial expansion rates (BCU-I, BCU-II, BCU-I and CRFs_BG) were much more prevalent among MSM than among heterosexual (HET) persons [3]. Thus, some HIV-1 Cuban clades may have spread faster than others because they encountered, by chance, local transmission chains with higher rates of partner exchange. Dissemination within a transmission network of small size and high rate of partner exchange may also explain the fast, but self limited, dissemination phase of clade BCU-II. Additional influence of virological factors cannot be excluded. These results must also be interpreted with caution as most growth rate estimates here obtained displayed quite large overlapping 95% HPD intervals. It has been proposed that Cuba's low rate of HIV infection is due to several factors that served to prevent sexual transmission of the virus, including: wide-scale HIV screening and subsequent contact tracing of HIV-positive individuals, mandatory quarantine of the first HIV-infected individuals at sanatoria, free access to a well structured public health system, comprehensive HIV education campaigns, coordinated work of Cuban government agencies and community, and restricted tourism between Cuba and western countries up to the early 1990s [43], [44], [45], [46]. The estimated initial growth rates of the major HIV-1 Cuban clades (∼0.4–1.6 year−1), however, were comparable to those obtained for different HIV-1 epidemics in the Americas (∼0.5–1.3 year−1) [38], [47], [48], [49], [50], [51], [52], Europe (∼0.4–1.5 year−1) [52], [53], [54], [55], Africa (∼0.2–0.8 year−1) [47], [52], [56], [57], [58] and Asia (∼0.8 year−1) [59]. This suggests that several factors may have contributed to delay the introduction and/or dissemination of HIV-1 in Cuba for many years; but once some HIV-1 strains got established in vulnerable HET and MSM transmission groups they spread quickly. In summary, this study indicates that only a few subtype B and non-B subtype founder viral strains were successfully disseminated in Cuba. Some of those HIV-1 viral strains were probably introduced from North America/Europe, central Africa and east Africa between the middle 1980s and the middle 1990s; whereas other were locally generated around the late 1990s. Changes in the social and economic landscapes of Cuba occurring at the beginning of the 1990s may have fueled the introduction and/or initial dissemination of major HIV-1 Cuban clades. Although the main HIV-1 Cuban lineages began to circulate at a rather late time of the AIDS pandemic, further dissemination within vulnerable groups was rapid. These results reinforce the importance of maintaining, reviewing and updating permanently the public health measures aimed at controlling the spread of those HIV-1 variants already established in the Cuban population. HIV-1 subtype B dataset. (PDF) Click here for additional data file. HIV-1 subtype C dataset. (PDF) Click here for additional data file. HIV-1 subtype G dataset. (PDF) Click here for additional data file. HIV-1 CRF18_cpx and CRF19_cpx/subtype D datasets. (PDF) Click here for additional data file. HIV-1 CRF20/23/24_cpx datasets. (PDF) Click here for additional data file. Nucleotide substitution models selected using jModeltest program. (PDF) Click here for additional data file.
  53 in total

1.  An automated genotyping system for analysis of HIV-1 and other microbial sequences.

Authors:  Tulio de Oliveira; Koen Deforche; Sharon Cassol; Mika Salminen; Dimitris Paraskevis; Chris Seebregts; Joe Snoeck; Estrelita Janse van Rensburg; Annemarie M J Wensing; David A van de Vijver; Charles A Boucher; Ricardo Camacho; Anne-Mieke Vandamme
Journal:  Bioinformatics       Date:  2005-08-02       Impact factor: 6.937

2.  Short communication: Evidences of recent decline in the expansion rate of the HIV type 1 subtype C and CRF31_BC epidemics in southern Brazil.

Authors:  Gonzalo Bello; Monick L Guimarães; Caroline P B Passaes; Sabrina E Matos Almeida; Valdilea G Veloso; Mariza G Morgado
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

3.  Spatiotemporal dynamics of the HIV-1 CRF06_cpx epidemic in Western Africa.

Authors:  Edson Delatorre; Gonzalo Bello
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

4.  Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: a 2005 study.

Authors:  Valerie Marechal; Valerie Jauvin; Benjamin Selekon; Josianne Leal; Pulcherie Pelembi; Valentin Fikouma; Philippe Gabrie; Luc Salva Heredeibona; Charles Goumba; Eugène Serdouma; Ahidjo Ayouba; Hervé Fleury
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

5.  Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay.

Authors:  Gonzalo Bello; Paula C Aulicino; Dora Ruchansky; Monick L Guimarães; Cecilio Lopez-Galindez; Concha Casado; Hector Chiparelli; Carlos Rocco; Andrea Mangano; Luisa Sen; Mariza G Morgado
Journal:  Retrovirology       Date:  2010-03-22       Impact factor: 4.602

6.  Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data.

Authors:  Alexei J Drummond; Geoff K Nicholls; Allen G Rodrigo; Wiremu Solomon
Journal:  Genetics       Date:  2002-07       Impact factor: 4.562

7.  The emergence of HIV/AIDS in the Americas and beyond.

Authors:  M Thomas P Gilbert; Andrew Rambaut; Gabriela Wlasiuk; Thomas J Spira; Arthur E Pitchenik; Michael Worobey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

8.  Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients.

Authors:  Liuber Y Machado; Marta Dubed; Héctor Díaz; Nancy Ruiz; Dania Romay; Neysi Váldes; Madeline Blanco; Eladio Silva
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-25       Impact factor: 2.205

9.  Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty.

Authors:  Guy Baele; Philippe Lemey; Trevor Bedford; Andrew Rambaut; Marc A Suchard; Alexander V Alekseyenko
Journal:  Mol Biol Evol       Date:  2012-03-07       Impact factor: 16.240

10.  Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil.

Authors:  Natalia Ristic; Jean Zukurov; Wagner Alkmim; Ricardo Sobhie Diaz; Luiz Mario Janini; Mario P S Chin
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

View more
  16 in total

1.  Time-scale of minor HIV-1 complex circulating recombinant forms from Central and West Africa.

Authors:  Edson Delatorre; Gonzalo Bello
Journal:  BMC Evol Biol       Date:  2016-11-16       Impact factor: 3.260

2.  Bridging epidemiology with population genetics in a low incidence MSM-driven HIV-1 subtype B epidemic in Central Europe.

Authors:  Maja M Lunar; Anne-Mieke Vandamme; Janez Tomažič; Primož Karner; Tomaž D Vovko; Blaž Pečavar; Gabriele Volčanšek; Mario Poljak; Ana B Abecasis
Journal:  BMC Infect Dis       Date:  2015-02-15       Impact factor: 3.090

3.  Origin and Population Dynamics of a Novel HIV-1 Subtype G Clade Circulating in Cape Verde and Portugal.

Authors:  Isabel Inês M de Pina-Araujo; Edson Delatorre; Monick L Guimarães; Mariza G Morgado; Gonzalo Bello
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

4.  CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba.

Authors:  Vivian Kouri; Ricardo Khouri; Yoan Alemán; Yeissel Abrahantes; Jurgen Vercauteren; Andrea-Clemencia Pineda-Peña; Kristof Theys; Sarah Megens; Michel Moutschen; Nico Pfeifer; Johan Van Weyenbergh; Ana B Pérez; Jorge Pérez; Lissette Pérez; Kristel Van Laethem; Anne-Mieke Vandamme
Journal:  EBioMedicine       Date:  2015-01-28       Impact factor: 8.143

5.  Spatiotemporal dynamics of dissemination of non-pandemic HIV-1 subtype B clades in the Caribbean region.

Authors:  Marina Cabello; Yaxelis Mendoza; Gonzalo Bello
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

6.  Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain.

Authors:  Carmen M González-Domenech; Isabel Viciana; Luis Delaye; María Luisa Mayorga; Rosario Palacios; Javier de la Torre; Francisco Jarilla; Manuel Castaño; Alfonso Del Arco; Encarnación Clavijo; Jesús Santos
Journal:  PLoS One       Date:  2018-01-08       Impact factor: 3.240

7.  Human immunodeficiency virus type 1 (HIV-1) subtype B epidemic in Panama is mainly driven by dissemination of country-specific clades.

Authors:  Yaxelis Mendoza; Alexander A Martínez; Juan Castillo Mewa; Claudia González; Claudia García-Morales; Santiago Avila-Ríos; Gustavo Reyes-Terán; Blas Armién; Juan M Pascale; Gonzalo Bello
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

8.  Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa.

Authors:  Edson Delatorre; Daiana Mir; Gonzalo Bello
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

9.  HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.

Authors:  Yaxelis Mendoza; Juan Castillo Mewa; Alexander A Martínez; Yamitzel Zaldívar; Néstor Sosa; Griselda Arteaga; Blas Armién; Christian T Bautista; Claudia García-Morales; Daniela Tapia-Trejo; Santiago Ávila-Ríos; Gustavo Reyes-Terán; Gonzalo Bello; Juan M Pascale
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

10.  Spatio-Temporal History of HIV-1 CRF35_AD in Afghanistan and Iran.

Authors:  Sana Eybpoosh; Abbas Bahrampour; Mohammad Karamouzian; Kayhan Azadmanesh; Fatemeh Jahanbakhsh; Ehsan Mostafavi; Farzaneh Zolala; Ali Akbar Haghdoost
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.